關於雜誌
     The Taiwan Society of Cardiology (TSOC) was founded in 1960, and has more than 1,700 cardiologists among its active membership.
Acta Cardiologica Sinica, the official journal of TSOC, had been published quarterly since 1985, and has been bimonthly since 2013.

 
    Acta Cardiologica Sinica welcomes all papers in the fields related to cardiovascular medicine, including basic research, vascular biology, clinical pharmacology, clinical trial, critical care medicine, coronary artery disease, interventional cardiology, arrhythmia and electrophysiology, atherosclerosis, hypertension, cardiomyopathy and heart failure, valvular and structure cardiac disease, pediatric cardiology, cardiovascular surgery, and so on. We received papers from more than 45 countries and regions of the world. Currently, 50% of the papers were submitted from Turkey, 20% from Taiwan, 15% from China, and 15% from the rest of the world.
 
    Acta Cardiologica Sinica was listed in SCIE in 2007, and had a journal impact factor (JIF) of 0.253 by 2009. The most recent JIF is 2.672 in 2020.
To further enhance the impact of Acta Cardiological Sinica to the global cardiology society, we welcome the submission of protocols of registered trials, guidelines or consensus statements from national or regional societies, and reviews of novel topics. We dedicate to speed up the editorial process and maintain the high-quality of articles published. Our goal is to make Acta Cardiologica Sinica the top cardiology journal in Asia. 
TOP